source
- Neion Bio secures $23M Series A to develop egg-based protein platform for biologicsNeion Bio announced it closed a $23 million Series A round that was oversubscribed. The funding will be used to advance its platform that leverages chicken eggs, extracting primordial germ cells f…
- Sensorion drops OTOF gene therapy to focus on GJB2-targeted hearing loss candidate after Regeneron approvalSensorion said it is ending development of its gene therapy SENS-501 for OTOF related hearing loss after a strategic review. The review concluded that the competitive landscape had changed signific…